444 third-party lab reports published 3 for the price of 2 on compound vials and capsules — put any 3 in your cart and the cheapest one is free, automatically. Solvents and lab supplies excluded. Ends Monday night. For research use only. 99.59% median purity across 251 lots Defense, VA, Federal and Public safety: your VerifyPass code adds 5% on top of 3 for the price of 2 · get verified 239 / 239 lots pass sterility

‹ Certificates Tesofensine Capsules Lot TES05002026-01

Lab report (Certificate of Analysis, COA)

Tesofensine Capsules · Tesofensine 557ug – TES05002026-01 – 60 capsules

Batch TES05002026-01 · tested March 11, 2026 (193 days ago) · released May 28, 2026

All tests passed

Batch
#TES05002026-01 5 tests
Mass
Tesofensine 557ug – TES05002026-01 – 60 capsules
Issuing lab accreditation
Vanguard · ISO 17025:2017 / A2LA #6377.01.01

No tier shown — see the tests listed on the report

Conformity: Not assessable — every reported unit passed on all 3 test rows · QA approval corroborates: Vanguard Laboratory, Tori Johnson, Operations Manager, 2026-03-11

Vanguard · issuing lab

Notes

Content audit 9 Sep 2026: lab id (blank) → V260218-22 005. Certificate prints: prints compound "Tesofensine", lot "TES05002026-01", lab id "V260218-22 005", content 557 mcg/unit

Reports for this lot

  1. Vanguard Laboratory this report · tested March 11, 2026 · 3 results · QA approvalVanguard · issuing labAll tests passed

Test by test

3 results on the report · 3 rows computed from the per-unit values · 1 ISO 17025:2017-accredited lab · each test used up to 1 vial from this lot (rows are not added together) · every row names the chapter or house rule it follows

Purity consistency between unitsNot on this report
no purity result printed on this lab report
Net peptide content (assay)Within limits
557.00 mcg/unit · 1 unit · USP <621> (procedural chapter)
Content consistency between unitsSingle measurement
1 unit printed (557 mcg/unit) · a between-unit spread needs two or more measured units
Heavy metalsWithin limits
4 elements non-detect · 1 unit · dose-scaled limits derived from USP <232> (limits chapter)

Residual solventsNot on this lot's panel
not on this report · this batch was tested to our earlier standard; newer batches get all 15 tests
TFA residualNot on this lot's panel
not on this report · this batch was tested to our earlier standard; newer batches get all 15 tests
Container closureNot on this lot's panel
not on this report · this batch was tested to our earlier standard; newer batches get all 15 tests
SolubilityNot on this lot's panel
not on this report · this batch was tested to our earlier standard; newer batches get all 15 tests
MicrobialPass
1 of 1 pass · 1 unit · no chapter named in the record; a screen
ConformityNot assessable
every reported unit passed on all 3 test rows · QA approval corroborates: Vanguard Laboratory, Tori Johnson, Operations Manager, 2026-03-11 · house check · agreement across all tests, unit to unit; QA approval corroborates

A chapter number names the method or limit a result follows; it does not describe the product. Chapters below 1000 are procedures or limits; 1000-series chapters are informational. USP <905> is the compendial test for between-unit uniformity: it assays 10 units, so a 3-unit certificate cannot yield its acceptance value — the content row is a house check with <905> named as the reference only.

Tested by Vanguard Laboratory · Released May 28, 2026

Permanent URL: https://peptidology.co/coa/tesofensine-capsules-lot-tes05002026-01/

For research use only. Not intended for diagnostic or therapeutic use.

This certificate has been viewed 9 times.